Abstract |
Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal.
|
Authors | Christoph Hatz, Robert van der Ploeg, Bernhard R Beck, Gert Frösner, Marjory Hunt, Christian Herzog |
Journal | Clinical and vaccine immunology : CVI
(Clin Vaccine Immunol)
Vol. 18
Issue 5
Pg. 885-7
(May 2011)
ISSN: 1556-679X [Electronic] United States |
PMID | 21411599
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hepatitis A Vaccines
- Vaccines, Virosome
- epaxal berna
|
Topics |
- Adult
- Aged
- Female
- Hepatitis A
(immunology, prevention & control)
- Hepatitis A Vaccines
(administration & dosage, immunology)
- Humans
- Immunization, Secondary
(methods)
- Immunologic Memory
- Male
- Middle Aged
- Time Factors
- Vaccines, Virosome
(administration & dosage, immunology)
|